Literature DB >> 18191469

Trichostatin A regulates peroxiredoxin expression and virulence of the parasite Entamoeba histolytica.

Elada Isakov1, Rama Siman-Tov, Christian Weber, Nancy Guillen, Serge Ankri.   

Abstract

Histone deacetylation is associated with a repressed chromatin state, and histone acetylase and deacetylase activities have been previously described in Entamoeba histolytica. To investigate their roles in the control of Entamoeba gene expression, the parasite was grown in 50 nM trichostatin A (TSA), an inhibitor of histone deacetylase. TSA enhanced the cytopathic and hemolytic activity of the parasite and its resistance to oxidative stress. We first focused our attention on peroxiredoxin, a protein previously associated with E. histolytica virulence and resistance to oxidative stress. We found that the expression of peroxiredoxin was increased after TSA treatment, but were unable to confirm that this was a direct consequence of histone modification at the promoter. By microarray analysis, we found that some other mRNAs encoding some other virulence factors, such as the galactose-inhibitable lectin small subunits, were also increased. The pattern of gene expression was surprisingly different from that previously described after treatment with 150 nM TSA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18191469     DOI: 10.1016/j.molbiopara.2007.11.014

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  12 in total

Review 1.  Peroxiredoxins in parasites.

Authors:  Michael C Gretes; Leslie B Poole; P Andrew Karplus
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

Review 2.  Using differential gene expression to study Entamoeba histolytica pathogenesis.

Authors:  Carol A Gilchrist; William A Petri
Journal:  Trends Parasitol       Date:  2009-02-13

3.  Acanthamoeba castellanii : growth on human cell layers reactivates attenuated properties after prolonged axenic culture.

Authors:  Martina Koehsler; David Leitsch; Michael Duchêne; Markus Nagl; Julia Walochnik
Journal:  FEMS Microbiol Lett       Date:  2009-06-05       Impact factor: 2.742

4.  Technical advances in trigger-induced RNA interference gene silencing in the parasite Entamoeba histolytica.

Authors:  Mohamed I Khalil; Bardees M Foda; Susmitha Suresh; Upinder Singh
Journal:  Int J Parasitol       Date:  2015-12-31       Impact factor: 3.981

Review 5.  Recent insights into Entamoeba development: identification of transcriptional networks associated with stage conversion.

Authors:  Upinder Singh; Gretchen M Ehrenkaufer
Journal:  Int J Parasitol       Date:  2008-10-04       Impact factor: 3.981

6.  Entamoeba histolytica modulates a complex repertoire of novel genes in response to oxidative and nitrosative stresses: implications for amebic pathogenesis.

Authors:  João B Vicente; Gretchen M Ehrenkaufer; Lígia M Saraiva; Miguel Teixeira; Upinder Singh
Journal:  Cell Microbiol       Date:  2008-09-05       Impact factor: 3.715

Review 7.  New insights into Entamoeba histolytica pathogenesis.

Authors:  Leigh A Baxt; Upinder Singh
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

8.  A detoxifying oxygen reductase in the anaerobic protozoan Entamoeba histolytica.

Authors:  João B Vicente; Vy Tran; Liliana Pinto; Miguel Teixeira; Upinder Singh
Journal:  Eukaryot Cell       Date:  2012-07-13

9.  Endoplasmic reticulum stress-sensing mechanism is activated in Entamoeba histolytica upon treatment with nitric oxide.

Authors:  Julien Santi-Rocca; Sherri Smith; Christian Weber; Erika Pineda; Chung-Chau Hon; Emma Saavedra; Alfonso Olivos-García; Sandrine Rousseau; Marie-Agnès Dillies; Jean-Yves Coppée; Nancy Guillén
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

10.  Differential expression and immunolocalization of antioxidant enzymes in Entamoeba histolytica isolates during metronidazole stress.

Authors:  Lakshmi Rani Iyer; Nishant Singh; Anil Kumar Verma; Jaishree Paul
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.